CHUV
Les activités du CHUV
MENU
Service
d'immunologie et allergie
Accueil > Research > Publications
Posters

 
Literature

 
Thesis

Publications

2010 - 2016


2010   |  2011   |  2012   |  2013   |  2014   |  2015   |  2016   |  2017


Publications : 2017 Debut de page

1: Noto A., Pantaleo G.
    B-cell abnormalities and impact on antibody response in HIV infection
Curr Opin HIV AIDS. 2017 May;12(3):203-208

Publications : 2016 Debut de page

1: Balam S., Jafarshad A., Servis C., Frank G., Reed S., Pink R., Druilhe P., Spertini F., Corradin G.
    Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice.
Vaccine 34:1566-1574
2: Banga R, Procopio A F, Noto A, Pollakis G, Cavassini M, Ohmiti K, Corpataux JM, de Leval L, Pantaleo G and Perreau M.
    PD-1+ and Tfh Cells Are Responsible for Persistent HIV-1 Transcription in Treated Aviremic Individuals.
Nat Med
3: Banga R, Procopio FA and Perreau M.
    Current approaches to assess HIV-1 persistence.
Curr Opin HIV AIDS
4: Bioley, G., Lassus, A., Terrettaz, J., Tranquart, F., and Corthesy, B
    Prophylactic immunization of mice with PLA2-loaded gas-filled microbubbles is protective against Th2-mediated honeybee venom allergy.
Clin. Exp. Allergy 46, 253-162.
5: Corthesy, B., Lassus, A., Terrettaz J., Tranquart, F., and Bioley, G.
    Efficacy of a therapeutic treatment using gas-filled microbubbles associated-phospholipase A2 in a mouse model of honeybee venom allergy.
Allergy 71, 957-966.
6: Ducreux J., Houssiau F.A., Vandepapelière P., Jorgensen C., Lazaro E., Spertini F., Colaone F., Roucairol C., Laborie M.
    Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study.
Croughs T. et al., In Press. Rheumatology (oxford, England).
7: Fellmann F, Wassenberg J, Angelini F, Perreau M, Arenas Ramirez N, Simon G, Boyman O, Demaria O, Christen-Zaech S, Hohl D, Belfiore M, Scheven-Gete A, Gilliet M, Bochud PY, Perrin Y, Beck Popovic M, Bart PA, Beckmann J, Martinet D, Hofer M
    IL-17RA and ADA2 knock-out in siblings with recurrent infections and chronic inflammation.
JACI
8: Mikulic, J., Longet, S., Favre, L., Benyacoub, J., and Corthesy B.
    Secretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of IL-10 and TGF-. Cell.
Cell. Mol. Immunol., in press.
9: Perraudin C., Bourdin A., Spertini F., Berger J., Bugnon O.
    Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.
Journal of Clinical Immunology 36:502-510
10: Perrottet N., Brunner-Ferber F., Grouzmann E., Spertini F., Biollaz J., Buclin T., Widmer N.
    Biases affecting injected doses of an experimental drug during clinical trials.
Trials 17:321.
11: Pigny, F., Lassus, A., Terrettaz, J., Tranquart, F., Corthesy B., and Bioley G.
    Intranasal vaccination with Salmonella-derived serodiminant secreted effector protein B associated with gas-filled microbubbles partially protects against gut infection in mice.
J. Infect. Dis. 214, 438-446.
12: Rochereau, N., Pavot, V., Verrier, B., Jospin, F., Ensinas, A., Genin, C., Corthesy, B., and Paul, S.
    Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.
J. Allergy Clin. Immunol. 137, 214-222.
13: Rokx C. and Vella S. and Pantaleo G. and Lévy Y. and Boucher C.A.
    Unite forces to validate biomarkers in the quest for lasting HIV remission
AIDS Jul 17;30(11):1859-60
14: Salvadé I., Aubert V., Venetz J.P., Golshayan D., Saouli A.C., Matter M., Rotman S., Pantaleo G., Pascual M.
    Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation.
Hum Immunol 2016 Jun;77 (6):483-9
15: Spertini F., DellaCorte G., Kettner A., de Blay F., Jacobsen L., Jutel M., Worm M., Charlon V., Reymond C.
    Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
Journal of Allergy and Clinical Immunology 138:162-168.
16: Volpi S, Picco P, Caorsi R, Candotti F, Gattorno M.
    Type I interferonopathies in pediatric rheumatology.
Pediatr Rheumatol Online J. 2016 Jun 4;14(1):35.
17: Volpi S, Santori E, Abernethy K, Mizui M, Dahlberg CI, Recher M, Capuder K, Csizmadia E, Ryan D, Mathew D, Tsokos GC, Snapper S, Westerberg LS, Thrasher AJ, Candotti F, Notarangelo LD.
    N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome.
Blood. 2016 Jan 14;127(2):216-20.

Publications : 2015 Debut de page

1: 6. Garcia Segarra N, Ballhausen D, Crawford H, Perreau M, Campos-Xavier B, van Spaendonck-Zwarts K, Vermeer C, Russo M, Zambelli PY, Stevenson B, Royer-Bertrand B, Rivolta C, Candotti F, Unger S, Munier FL, Superti-Furga A, Bonafé L.
    NBAS mutations cause a multisystem disorder involving bone, connective tissue, liver, immune system, and retina.
Am J Med Genet A
2: Banga R, Procopio F, Cavassini M and Perreau M.
    In Vitro Reactivation of Replication Competent and Infectious HIV-1 by HDAC Inhibitors.
J. Virol.
3: Banga R., Procopio F.A., Noto A., Pollakis G., Cavassini M., Ohmiti K., Corpataux J.M., de Leval L., Pantaleo G., Perreau M.
    PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals.
Nature Medicine 22(7) pp. 754-761.
4: Bioley, G., Lassus, A., Terrettaz, J., Tranquart, F., Corthesy, B
    Long-term persistence of immunity induced by OVA-coupled gas-filled microbubble vaccination partially protects mice against infection by OVA-expressing Listeria.
Biomaterials 57, 153-160.
5: Corey L., Gilbert P.B., Tomaras G.D., Haynes B.F., Pantaleo G., Fauci A.S.
    Immune correlates of vaccine protection against HIV-1 acquisition.
Science Translational Medicine 7(310) pp. 310rv7.
6: Crestani E, Volpi S, Candotti F, Giliani S, Notarangelo LD, Chu J, Aldave Becerra JC, Buchbinder D, Chou J, Geha RS, Kanariou M, King A, Mazza C, Moratto D, Sokolic R, Garabedian E, Porta F, Putti MC, Wakim RH, Tsitsikov E, Pai SY, Notarangelo LD.
    Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
J Allergy Clin Immunol. 2015 Nov;136(5):1401-4.e1-3.
7: Delaloye J., Filali-Mouhim A., Cameron M.J., Haddad E.K., Harari A., Goulet J.P., Gomez C.E., Perdiguero B., Esteban M., Pantaleo G.
    Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
Journal of Virology 89(7) pp. 3819-3832.
8: Elliott A., Nerima B., Bagaya B., Kambugu A., Joloba M., Cose S., Pantaleo G., Yazdanbakhsh M., Mabey D., Dunne D.
    Capacity for science in sub-Saharan Africa.
Lancet 385(9986) pp. 2435-2437.
9: Herderschee J., Fenwick C., Pantaleo G., Roger T., Calandra T.
    Emerging single-cell technologies in immunology.
Journal of Leukocyte Biology 98(1) pp. 23-32.
10: Hulot S.L., Korber B., Giorgi E.E., Vandergrift N., Saunders K.O., Balachandran H., Mach L.V., Lifton M.A., Pantaleo G., Tartaglia J.
    Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
Journal of Virology 89(12) pp. 6462-6480.
11: Ikawa Y, Hess R, Dorward H, Cullinane AR, Huizing M, Gochuico BR, Gahl WA, Candotti F.
    In vitro functional correction of Hermansky-Pudlak Syndrome type-1 by lentiviral-mediated gene transfer.
Mol Genet Metab. 2015 Jan;114(1):62-5.
12: Johnston JJ, Lewis KL, Ng D, Singh LN, Wynter J, Brewer C, Brooks BP, Brownell I, Candotti F, Gonsalves SG, Hart SP, Kong HH, Rother KI, Sokolic R, Solomon BD, Zein WM, Cooper DN, Stenson PD, Mullikin JC, Biesecker LG.
    Individualized iterative phenotyping for genome-wide analysis of loss-of-function mutations.
Am J Hum Genet. 2015 Jun 4;96(6):913-25.
13: Kolhatkar NS, Brahmandam A, Thouvenel CD, Becker-Herman S, Jacobs HM, Schwartz MA, Allenspach EJ, Khim S, Panigrahi AK, Luning Prak ET, Thrasher AJ, Notarangelo LD, Candotti F, Torgerson TR, Sanz I, Rawlings DJ.
    Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome.
J Exp Med. 2015 Sep 21;212(10):1663-77.
14: Komarow HD, Sokolic R, Hershfield MS, Kohn DB, Young M, Metcalfe DD, Candotti F.
    Impulse oscillometry identifies peripheral airway dysfunction in children with adenosine deaminase deficiency.
Orphanet J Rare Dis. 2015 Dec 18;10:159.
15: Lin L., Frelinger J., Jiang W., Finak G., Seshadri C., Bart P.A., Pantaleo G., McElrath J., DeRosa S., Gottardo R.
    Identification and visualization of multidimensional antigen-specific T-cell populations in polychromatic cytometry data.
Cytometry. Part A 87(7) pp. 675-682.
16: Mooij P., Koopman G., Drijfhout J.W., Nieuwenhuis I.G., Beenhakker N., Koestler J., Bogers W.M., Wagner R., Esteban M., Pantaleo G.
    Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1.
Journal of General Virology 96(Pt 6) pp. 1478-1483.
17: Otsu M, Yamada M, Nakajima S, Kida M, Maeyama Y, Hatano N, Toita N, Takezaki S, Okura Y, Kobayashi R, Matsumoto Y, Tatsuzawa O, Tsuchida F, Kato S, Kitagawa M, Mineno J, Hershfield MS, Bali P, Candotti F, Onodera M, Kawamura N, Sakiyama Y, Ariga T.
    Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
J Clin Immunol. 2015 May;35(4):384-98.
18: Pala F, Morbach H, Castiello MC, Schickel JN, Scaramuzza S, Chamberlain N, Cassani B, Glauzy S, Romberg N, Candotti F, Aiuti A, Bosticardo M, Villa A, Meffre E.
    Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients.
J Clin Invest. 2015 Oct 1;125(10):3941-51.
19: Rissone A, Weinacht KG, la Marca G, Bishop K, Giocaliere E, Jagadeesh J, Felgentreff K, Dobbs K, Al-Herz W, Jones M, Chandrasekharappa S, Kirby M, Wincovitch S, Simon KL, Itan Y, DeVine A, Schlaeger T, Schambach A, Sood R, Notarangelo LD, Candotti F.
    Reticular dysgenesis-associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress.
J Exp Med. 2015 Jul 27;212(8):1185-202.
20: Rochereau, N., Pavot, V., Verrier, B., Ensinas, A., Genin, C., Corthesy, B., Paul, S.
    Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells.
Eur. J. Immunol., 45, 773-779.
21: Rozot V, Patrizia A, Vigano S, Mazza-Stalder J, Idrizi E, Day C.L, Perreau M, Lazor-Blanchet C, Ohmiti K, Goletti D, Bart PA, Hanekom W, Scriba T J, Nicod L, Pantaleo G and Harari A
    The Combined Use of M. tuberculosis-specific CD4 and CD8 T-Cell Responses Is a Powerful Diagnostic Tool of Active Tuberculosis.
Clinical Infectious diseases 1;60:432-7.
22: Segarra NG, Ballhausen D, Crawford H, Perreau M, Campos-Xavier B, van Spaendonck-Zwarts K, Vermeer C, Russo M, Zambelli PY, Stevenson B, Royer-Bertrand B, Rivolta C, Candotti F, Unger S, Munier FL, Superti-Furga A, Bonafé L.
    NBAS mutations cause a multisystem disorder involving bone, connective tissue, liver, immune system, and retina.
Am J Med Genet A. 2015 Dec;167A(12):2902-12.
23: Sokolic R, Oden N, Candotti F.
    Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott-Aldrich Syndrome.
Front Pediatr. 2015 Jun 1;3:49.
24: Spertini F., DellaCorte G., Kettner A., de Blay F., Jacobsen L., Jutel M., Worm M., Charlon V., Reymond C.
    Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
Journal of Allergy and Clinical Immunology 138:162-168.
25: Yokoyama T, Yoshizaki A, Simon KL, Kirby MR, Anderson SM, Candotti F.
    Age-Dependent Defects of Regulatory B Cells in Wiskott-Aldrich Syndrome Gene Knockout Mice.
PLoS One. 2015 Oct 8;10(10):e0139729.
26: Zufferey P, Perreau M, So A.
    High level of anti-drug antibodies after intra-articular injection of anti-TNF.
Rheumatology (Oxford)

Publications : 2014 Debut de page

1: Abed J., Lebreton C., Champier G., Cuvillier A., Cogné M., Meresse B., Dugave C., Garfa-Traoré M., Corthésy B., Cerf-Bensussan N. and Heyman M.
    Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response.
Mucosal Immunol. 2014, 7:315-324.
2: Boyman O., Comte D., Spertini F.
    Adverse reactions to biologic agents and their medical management.
Nature Reviews. Rheumatology 10:612-627
3: Castro E., Zhao H., Cavassini M., Mullins J.I., Pantaleo G., Bart P.A.
    HIV-1 superinfection with a triple-class drug-resistant strain in a patient successfully controlled with antiretroviral treatment.
Aids 28(12) pp. 1840-1844.
4: Cortese A., Pantaleo G., IdaLucia F., Vatrella A., Cozzolino I., Di Crescenzo V., Amato M.,
    Bone and soft tissue non-Hodgkin lymphoma of the maxillofacial area: Report of two cases, literature review and new therapeutic strategies.
International Journal of Surgery (london, England).
5: Cubas R and Perreau M.
    The dysfunction of T follicular helper cells.
Curr Opin HIV AIDS. 2014 Sep;9(5):485-91.
6: Drescher S.M., von Wyl V., Yang W.L., Böni J., Yerly S., Shah C., Aubert V., Klimkait T., Taffé P., Furrer H., Battegay M., Ambrosioni J., Cavassini M., Bernasconi E., Vernazza P.L., Ledergerber B., Günthard H.F., Kouyos R.D. and the Swiss HIV Cohort Study.
    Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study.
Clin. Infect. Dis. 2014, 58:285-294.
7: Du Pasquier R.A., Pinschewer D.D. and Merkler D.
    Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.
CNS Drugs. 2014 [Epub ahead of print].
8: Gherlone E., Mandelli F., Capparè P., Pantaleo G., Traini T., Ferrini F.
    A 3 years retrospective study of survival for zirconia-based single crowns fabricated from intraoral digital impressions.
Journal of Dentistry 42(9) pp. 1151-1155.
9: Herrera D., Vásquez C., Corthésy B., Franco M.A. and Angel J.
    Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.
Hum. Vaccin. Immunother. 2013 [Epub ahead of print].
10: Jilek S., Mathias A., Canales M., Lysandropoulos A., Pantaleo G., Schluep M. and Du Pasquier R.A.
    Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients.
Mult. Scler. 2013 [Epub ahead of print].
11: Kouyos R.D., Rauch A., Böni J., Yerly S., Shah C., Aubert V., Klimkait T., Kovari H., Calmy A., Cavassini M., Battegay M., Vernazza P.L., Bernasconi E., Ledergerber B., Günthard H.F. and the Swiss HIV Cohort Study (SHCS).
    Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV.
Int. J. Epidemiol. 2014 [Epub ahead of print].
12: Longet, S., Vonarburg, C., Loetscher, M., Miescher, S., Zuercher, A., Corthesy, B.
    Reconstituted human plasma-derived secretory-like IgM and IgA maintain the barrier function of epithelial cells infected with an enteropathogen.
J. Biol. Chem. 289, 21617-21626.
13: Maître S., Maniu C.M., Buss G., Maillard M.H., Spertini F., Ribi C.
    Allergie ou intolérance alimentaire [Food allergy or food intolerance?].
Revue Médicale Suisse 10:846-50, 852-3.
14: Mathias, A., Pais, B., Favre, L., Benyacoub, J., and Corthesy, B.
    Role of secretory IgA in the mucosal sensing of commensal bacteria.
Gut Microbes 5, 688-695.
15: Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, Roger T, Lacabaratz C, Bart PA, Levy Y, Pantaleo G.
    Exhaustion of Bacteria-Specific CD4 T-Cells and Microbial Translocation in Common Variable Immunodeficiency Disorders.
J Exp Med. 22;211(10):2033-45. doi: 10.1084/jem.20140039
16: Perrin Y., Nutten S., Audran R., Berger B., Bibiloni R., Wassenberg J., Barbier N., Aubert V., Moulin J., Singh A., Magliola C., Mercenier A. and Spertini F.
    Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis.
Clin. Transl. Allergy 2014, 6:4:1.
17: Pollard R.B., Rockstroh J.K., Pantaleo G, Asmuth D.M., Peters B., Lazzarin A., Garcia F., Ellefsen K., Podzamczer D., van Lunzen J., Arastéh K., Schürmann D., Clotet B., Hardy W.D., Mitsuyasu R., Moyle G., Plettenberg A., Fisher M., Fätkenheuer G., Fischl M., Taiwo B., Baksaas I., Jolliffe D., Persson S., Jelmert O., Hovden A.O., Sommerfelt M.A., Wendel-Hansen V. and Sørensen B.
    Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
Lancet Infect. Dis. 2014, 14:291-300.
18: Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Bienvenu B., Ruivard M., Terrier B., Pagnoux C., Mouthon L., Guillevin L.; French Vasculitis Study Group (FVSG).
    Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors.
Autoimmun. Rev. 2014, 13:197-205.
19: Spatola M., Rossetti A.O., Michel P., Kuntzer T., Benninger D., Nater B., Démonet J.F., Schluep M., Du Pasquier R.A. and Vingerhoets F.
    News in neurology 2013.
Rev. Med. Suisse 2014, 10:78-81.
20: Spertini F., Perrin Y., Audran R., Pellaton C., Boudousquié C., Barbier N., Thierry A.C., Charlon V., Reymond C.
    Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.
Journal of Allergy and Clinical Immunology 134: 239-240.e13.
21: Viganò S, Banga R, Bellanger F, Pellaton C, Farina A, Comte D, Harari A, Perreau M.
    CD160-Associated CD8 T-Cell Functional Impairment Is Independent of PD-1 Expression.
PLoS Pathog; 10
22: Wu D.J., Zhou W., Enouz S., Orrú V., Stanford S.M., Maine C.J., Rapini N., Sawatzke K., Engel I., Fiorillo E., Sherman L.A., Kronenberg M., Zehn D., Peterson E. and Bottini N.
    Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells.
PLoS One 2014, 9:e86677.
23: Zehn D., Roepke S., Weakly K., Bevan M.J. and Prlic M.
    Inflammation and TCR signal strength determine the breadth of the T cell response in a bim-dependent manner.
J. Immunol. 2014, 192:200-205.

Publications : 2013 Debut de page

1: Alvarez V., Rossetti A.O., Michel P., Kuntzer T., Nater B., Démonet J.F., Schluep M., Du Pasquier R. and Vingerhoets F.
    2012: news in neurology.
Rev. Med. Suisse 2013, 9:62-65.
2: Beerenwinkel N., Montazeri H., Schuhmacher H., Knupfer P., von Wyl V., Furrer H., Battegay M., Hirschel B., Cavassini M., Vernazza P., Bernasconi E., Yerly S., Böni J., Klimkait T., Cellerai C., Günthard H.F. and Swiss HIV Cohort Study.
    The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.
PLoS Comput. Biol. 2013, 9:e1003203.
3: Bianchi M.P., Letovanec I., Spertini F., Nicod L.P. and Lazor R.
    Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency.
Rev. Med. Suisse 2013, 9:2175-2180.
4: Bioley G., Zehn D., Lassus A., Terrettaz J., Tranquart F. and Corthésy B.
    The effect of vaccines based on ovalbumin coupled to gas-filled microbubbles for reducing infection by ovalbumin-expressing Listeria monocytogenes.
Biomaterials 2013, 34:5423-5430.
5: Buss G., Cattin V., Spring P., Malinverni R. and Gilliet M.
    Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis.
Dermatology 2013, 226:289-297.
6: Buss G., Petitpierre S., Beer D., Zufferey P. and Bart P.-A.
    Polymyalgia rheumatica en 2012.
Forum Med. Suisse 2013, 13:136-140.
7: Cavassini M. and Du Pasquier R.A.
    A light in the cognitive fog ?
Antivir. Ther. 2013, 18:149-451.
8: Chappuis S., Ribi C. and Spertini F.
    Management of adverse events induced by TNFalpha blocking agents.
Rev. Med. Suisse 2013, 9:12-16.
9: Chappuis S., Ribi C., Greub G. and Spertini F.
    Peripheral blood eosinophilia: diagnostic value and further assessment.
Rev. Med. Suisse 2013, 9:819-825.
10: Chu T., Tyznik A.J., Roepke S., Berkley A.M., Woodward-Davis A., Pattacini L., Bevan M.J., Zehn D. and Prlic M.
    Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner.
Cell. Rep. 2013, 3:701-708.
11: Cooper D.A. and Pantaleo G.
    Thirty years of HIV: what have we learned ?
Curr. Opin. HIV AIDS 2013, 8:304-305.
12: Corthésy B.
    Role of secretory IgA in infection and maintenance of homeostasis.
Autoimmun Rev. 2013, 12:661-665.
13: Corthésy B.
    Multi-faceted functions of secretory IgA at mucosal surfaces.
Front. Immunol. 2013 Jul 12;4:185.
14: Cubas R.A., Mudd J.C., Savoye A.-L., Perreau M., van Grevenynghe J., Metcalf T., Connick E., Meditz A., Freeman G.J., Abesada-Terk Jr G., Jacobson J.M., Brooks A.D., Crotty S., Estes J.D., Pantaleo G., Lederman M.M. and Haddad E.K.
    Inadequate T follicular cell help impairs B cell immunity during HIV infection.
Nat. Med. 2013, 19:494-499.
15: Diana J., Moura I.C., Vaugier C., Gestin A., Tissandie E., Beaudoin L., Corthésy B., Hocini H., Lehuen A. and Monteiro RC.
    Secretory IgA induces tolerogenic dendritic cells through SIGNR1 dampening autoimmunity in mice.
J. Immunol. 2013, 191:2335-2343.
16: Du Pasquier R.A. and Lalive P.H.
    Head inflammation.
Rev. Med. Suisse 2013, 9:907.
17: Du Pasquier R.A., Jilek S., Kalubi M., Yerly S., Fux C.A., Gutmann C., Cusini A., Günthard H.F., Cavassini M., Vernazza P.L. and the Swiss HIV Cohort Study.
    Marked Increase of the Astrocytic Marker S100B in the Cerebrospinal Fluid of HIV-infected Patients on LPV/r-Monotherapy.
AIDS 2013, 27:203-210.
18: Dudda J.C., Salaun B., Ji Y., Palmer D.C., Monnot G.C., Merck E., Boudousquie C., Utzschneider D.T., Escobar T.M., Perret R., Muljo S.A., Hebeisen M., Rufer N., Zehn D., Donda A., Restifo N.P., Held W., Gattinoni L. and Romero P.
    MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.
Immunity 2013, 38:742-753.
19: Esteban J.I., van Helden J., Alborino F., Bürgisser P., Cellerai C., Pantaleo G., Eiras A., Rodriguez M.I., Ghisetti V., Gleich M., Imdahl R., Kaiser C., Möller P., Wetlitzky O., Segovia M., Schennach H. and Mühlbacher A.
    Multicenter evaluation of the elecsys® anti-HCV II assay for the diagnosis of hepatitis C virus infection.
J. Med. Virol. 2013, 85:1362-1368.
20: Ferrini W., Aubert V., Balmer A., Munier F.L. and Abouzeid H.
    Anterior uveitis and cataract after rubella vaccination: a case report of a 12-month-old girl.
Pediatrics 2013, 132:e1035-1038.
21: Godat S., Velin D., Aubert V., Nydegger A., Schoepfer A.M. and Maillard M.H.
    An update on celiac disease.
Rev. Med. Suisse 2013, 9:1584-1589.
22: Granziera C., Daducci A., Simioni S., Cavassini M., Roche A., Meskaldji D., Kober T., Metral M., Calmy A., Helms G., Hirschel B., Lazeyras F., Meuli R., Krueger G. and Du Pasquier R.A.
    Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field.
PLoS One 2013, 8:e72547.
23: Hafner A.M., Corthésy B. and Merkle H.P.
    Particulate formulations for the delivery of Poly(I:C) as vaccine adjuvant.
Adv. Drug Deliv. Rev. 2013, 65:1386-1399.
24: Hebeisen M., Oberle S.G., Presotto D., Speiser D.E., Zehn D. and Rufer N.
    Molecular insights for optimizing T cell receptor specificity against cancer.
Front. Immunol. 2013, 4:154.
25: Jilek S., Schluep M., Pantaleo G. and Du Pasquier R.A.
    MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
Neurol. Sci. 2013, 34:539-543.
26: Karoui O., Leimgruber A. and Spertini F.
    Interests of recombinant allergens in the practice of allergy.
Rev. Med. Suisse 2013, 9:22-27.
27: Lalive P.H., Du Pasquier R.A., Chizzolini C. and Kuntzer T.
    Dysimmune neuromuscular disorders: diagnostic challenges and new ways of management.
Rev. Med. Suisse 2013, 9:934-939.
28: Lange C.M., Bibert S., Dufour J.F., Cellerai C., Cerny A., Heim M.H., Kaiser L., Malinverni R., Müllhaupt B., Negro F., Semela D., Moradpour D., Kutalik Z., Bochud P.Y. and Swiss Hepatitis C Cohort Study Group.
    Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.
J. Hepatol. 2013, 59:504-509.
29: Lange C.M., Miki D., Ochi H., Nischalke H.D., Bojunga J., Bibert S., Morikawa K., Gouttenoire J., Cerny A., Dufour J.F., Gorgievski-Hrisoho M., Heim M.H., Malinverni R., Müllhaupt B., Negro F., Semela D., Kutalik Z., Müller T., Spengler U., Berg T., Chayama K., Moradpour D., Bochud P.Y., Hiroshima Liver Study Group and Swiss Hepatitis C Cohort Study Group.
    Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development.
PLoS One 2013, 8:e64053.
30: Lauwerys B.R., Hachulla E., Spertini F., Lazaro E., Jorgensen C., Mariette X., Haelterman E., Grouard-Vogel G., Fanget B., Dhellin O., Vandepapelière P. and Houssiau F.A.
    Down-regulation of Interferon signature in systemic lupus erythematosus patients by active immunization with Interferon α-Kinoid.
Arthritis Rheum. 2013, 65:447-456.
31: Legat A., Speiser D.E., Pircher H., Zehn D. and Fuertes Marraco S.A.
    Inhibitory receptor expression depends more dominantly on differentiation and activation than "Exhaustion" of human CD8 T cells.
Front. Immunol. 2013, 4:455.
32: Longet S., Miled S., Loetscher M., Miescher S., Zuercher A. and Corthésy B.
    Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodies.
J. Biol. Chem. 2013, 288:4085-4094.
33: Maniu C.M., Buss G., Feldmeyer L., Spertini F. and Ribi C.
    Severe delayed drug hypersensitivity reactions.
Rev. Med. Suisse 2013, 9:803-804, 806-811.
34: Maniu C.M., Ribi C. and Spertini F.
    Systemic mastocytosis - new therapeutic strategies.
Rev. Med. Suisse 2013, 9:17-21.
35: Marais B.J., Lönnroth K., Lawn S.D., Migliori G.B., Mwaba P., Glaziou P., Bates M., Colagiuri R., Zijenah L., Swaminathan S., Memish Z.A., Pletschette M., Hoelscher M., Abubakar I., Hasan R., Zafar A., Pantaleo G., Craig G., Kim P., Maeurer M., Schito M. and Zumla A.
    Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts.
Lancet Infect Dis. 2013, 13:436-448.
36: Mathias A., Longet S. and Corthésy B.
    Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri.
Infect. Immun. 2013, 81:3027-3034.
37: Metzner K.J., Scherrer A.U., Preiswerk B., Joos B., von Wyl V., Leemann C., Rieder P., Braun D., Grube C., Kuster H., Böni J., Yerly S., Klimkait T., Aubert V., Furrer H., Battegay M., Vernazza P.L., Cavassini M., Calmy A., Bernasconi E., Weber R., Günthard H.F.; the Swiss HIV Cohort Study.
    Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.
J. Infect. Dis. 2013, 208:1102-1112.
38: Muehlbacher A., Schennach H., van Helden J., Hebell T., Pantaleo G., Bürgisser P., Cellerai C., Permpikul P., Rodriguez M.I., Eiras A., Alborino F., Cunningham P., Axelsson M., Andersson S., Wetlitzky O., Kaiser C., Möller P. and de Sousa G.
    Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay.
Med. Microbiol. Immunol. 2013, 202:77-86.
39: Pantaleo G. and Lévy Y.
    Vaccine and immunotherapeutic interventions.
Curr. Opin. HIV AIDS 2013, 8:236-242.
40: Pardon A., Aubert V. and Bart P.-A.
    Biomarqueurs en immunologie générale.
Rev. Med. Suisse 2013, 9:1982-1991.
41: Parfenov V., Schluep M. and Du Pasquier R.
    Assessing risks of multiple sclerosis therapies.
J. Neurol. Sci. 2013, 332:59-65.
42: Pellaton C., Perrin Y., Boudousquié C., Barbier N., Wassenberg J., Corradin G., Thierry A.C., Audran R., Reymond C. and Spertini F.
    Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides.
Clin. Transl. Allergy 2013, 3:17.
43: Perdiguero B., Gómez C.E., Di Pilato M., Sorzano C.O., Delaloye J., Roger T., Calandra T., Pantaleo G. and Esteban M.
    Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-C.
PLoS One 2013, 8:e74831.
44: Perreau M, Levy Y, Pantaleo G.
    Immune response to HIV.
Curr Opin HIV AIDS. 2013 Jul;8(4):333-40
45: Perreau M., Rozot V., Welles H.C., Belluti-Enders F., Vigano S., Maillard M., Dorta G., Mazza-Stalder J., Bart P.A., Roger T., Calandra T., Nicod L. and Harari A.
    Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease.
Eur. J. Immunol. 2013, 43:939-948.
46: Perreau M., Savoye A.-L., De Crignis E., Corpataux J.-M., Cubas R., Haddad E.K., De Leval L., Graziosi C. and Pantaleo G.
    Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production.
J. Exp. Med. 2013, 210:143-156.
47: Perrottet N., Aubert V., Venetz J.-P., Ugolini E., Matter M., Pannatier A. and Pascual M.
    Evolving trends in the costs associated with hospital use of immunosuppressive drugs.
Transplantation 2013, 95:e24-e25.
48: Rochereau N., Drocourt D., Perouzel E., Pavot V., Redelinghuys P., Brown G.D., Tiraby G., Roblin X., Verrier B., Genin C., Corthésy B. and Paul S.
    Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells.
PLoS Biol. 2013, 11:e1001658.
49: Rozot V., Vigano S., Mazza-Stalder J., Idrizi E., Day C.L., Perreau M., Lazor-Blanchet C., Petruccioli E., Hanekom W., Goletti D., Bart P.-A., Nicod L., Pantaleo G. and Harari A.
    Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease.
Eur. J. Immunol. 2013, 43:1568-1577.
50: Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Stern M., Pagnoux C., Mouthon L. and Guillevin L., for the French Vasculitis Study Group.
    Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials.
J. Autoimmun. 2013, 43:60-69.
51: Schluep M., Lalive P.H. and Du Pasquier RA.
    New treatment options in multiple sclerosis and their complications.
Rev. Med. Suisse 2013, 9:940-943.
52: Schnegg A., Bürgisser P., André C., Kenfak-Foguena A., Canellini G., Moradpour D., Abravanel F., Izopet J., Cavassini M. and Darling K.E.
    An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population.
PLoS One 2013, 8:e62980.
53: Schnider C., Seebach J.D., Ribi C. and Spertini F.
    Systemic and neurological uses of immunosuppressive agents.
Rev. Med. Suisse 2013, 9:915-921.
54: Schuepbach J., Gebhardt M.D., Scherrer A.U., Bisset L.R., Niederhauser C., Regenass S., Yerly S., Aubert V., Suter F., Pfister S., Martinetti G., Andreutti C., Klimkait T., Brandenberger M., Günthard H.F. and the Swiss HIV Cohort Study.
    Simple estimation of incident HIV infection rates in notification Cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.
PLoS One 2013, 8:e71662.
55: Seebach J.D. and Spertini F.
    The bureaucratic jungle of off-list and off-label patients.
Rev. Med. Suisse 2013, 9:795-796.
56: Simioni S., Cavassini M., Annoni J.M., Métral M., Iglesias K., Rimbault Abraham A., Jilek S., Calmy A., Müller H., Fayet-Mello A., Giacobini E., Hirschel B. and Du Pasquier R.A.
    Rivastigmine for HIV-associated neurocognitive disorders: A randomized crossover pilot study.
Neurology 2013, 80:553-560.
57: Spertini F., Audran R., Lurati F., Ofori-Anyinam O., Zysset F., Vandepapelière P., Moris P., Demoitié M.A., Mettens P., Vinals C., Vastiau I., Jongert E., Cohen J. and Ballou W.R.
    The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study.
Tuberculosis 2013, 93:179-188.
58: Spring P., Vernez M., Maniu C.M. and Hohl D.
    Localized interstitial granuloma annulare induced by subcutaneous injections for desensitization.
Dermatol. Online J. 2013, 19:18572.
59: Stark R., Hartung A., Zehn D., Frentsch M. and Thiel A.
    IL-12-mediated STAT4 signaling and TCR signal strength cooperate in the induction of CD40L in human and mouse CD8+ T cells.
Eur. J. Immunol. 2013, 43:1511-1517.
60: Utzschneider D.T., Legat A., Fuertes Marraco S.A., Carrié L., Luescher I., Speiser D.E. and Zehn D.
    T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion.
Nat. Immunol. 2013, 14:603-610.
61: Viganò S., Bellutti Enders F., Miconnet I., Cellerai C., Savoye A.-L., Rozot V., Perreau M., Faouzi M., Ohmiti K., Cavassini M., Bart P.-A., Pantaleo G. and Harari A.
    Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells.
PLoS Pathog. 2013, 9:e1003423.
62: Vionnet J., Petitpierre S., Fumeaux A., Meuli R., Spertini F. and Comte D.
    Allergy to radiographic contrast media.
Rev. Med. Suisse 2013, 9:812-818.
63: Zahednasab H., Du Pasquier R.A., Canales M. and Schluep M.
    Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management ?
Neurology 2013, 81:97-98.
64: Zekeridou A., Rossetti A.O., Hottinger A.F. and Du Pasquier RA.
    Anti-neuronal antibodies: a rapidly developing field.
Rev. Med. Suisse 2013, 9:909-914.

Publications : 2012 Debut de page

1: Antoniol C., Jilek S., Schluep M., Mercier N., Canales M., Le Goff G., Campiche C., Pantaleo G. and Du Pasquier R.A.
    Impairement of JCV-specific T cell response by corticotherapy: impact on PML-IRIS management ?
Neurology 2012, 79:2258-2264.
2: Antoniol C., Jilek S., Schluep M., Mercier N., Canales M., Le Goff G., Campiche C., Pantaleo G., Du Pasquier R.A.
    Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
Neurology 79(23) pp. 2258-2264.
3: Aubert V. and Duchosal M.A.
    Gammapathies monoclonales: Utilisation des chaînes légères libres sériques.
Forum Med. Suisse 2012, 12:576-577.
4: Bioley G., Bussat P., Lassus A., Schneider M., Terrettaz J. and Corthésy B.
    The phagocytosis of gas-filled microbubbles by human and murine antigen-presenting cells.
Biomaterials 2012, 33:333-342.
5: Bioley G., Lassus A., Bussat P., Terrettaz J., Tranquart F. and Corthésy B.
    Gas-filled microbubble-mediated delivery of antigen and the induction of immune responses.
Biomaterials 2012, 33:5935-5946.
6: Boyman O., Krieg C., Letourneau S., Webster K., Surh C.D. and Sprent J.
    Selectively expanding subsets of T cells in mice by injection of interleukin-2/antibody complexes: implications for transplantation tolerance.
Transplant Proc. 2012, 44:1032-1034.
7: Buss G., Comte D., Spertini F., Bart P.-A. and Petitpierre S.
    Common variable immune deficiency: what you need to know.
Rev. Med. Suisse 2012, 8:859-864.
8: Chabwine J.N., Lhermitte B., Da Silva M.O.P., Buss G., Maeder P. and Du Pasquier R.A.
    Progressive multifocal leukoencephalopathy in a patient with transitory lymphopenia.
Neurology 2012, 78:2000-2002.
9: Chabwine J.N., Rossetti A.R., Hirt L., Kuntzer T., Schluep M., Michel P., Démonet J.F., du Pasquier R.A. and Vingerhoets F.G.
    Neurology.
Rev. Med. Suisse 2012, 8:46-50.
10: Comte D., Petitpierre S., Spertini F. and Bart P.-A.
    Allergy to beta-lactam antibiotics.
Rev. Med. Suisse 2012, 8:836, 838-842.
11: Darling K.E., Hugli O., Mamin R., Cellerai C., Martenet S., Berney A., Peters S., Du Pasquier R.A., Bodenmann P. and Cavassini M.
    HIV testing practices by clinical Service before and after revised testing guidelines in a Swiss University Hospital.
PLoS One 2012, 7:e39299.
12: De Crignis E., Guglietta S., Foley B.T., Negroni M., Di Narzo A.F., Waelti Da Costa V., Cavassini M., Bart P.-A., Pantaleo G. and Graziosi C.
    Nonrandom distribution of cryptic repeating triplets of purines and pyrimidines (RNY)n in gp120 of HIV type1.
AIDS Res. Hum. Retroviruses 2012, 28:493-504.
13: Enouz S., Carrié L., Merkler D., Bevan M.J. and Zehn D.
    Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection.
J. Exp. Med. 2012, 209:1769-1779.
14: Erba P., Espinoza D., Koch N., Christen T., Serov A. and Raffoul W.
    FluxEXPLORER: a new high-speed laser Doppler imaging system for the assessment of burn injuries.
Skin Res. Technol. 2012, 18:456-461.
15: Gómez C.E., Perdiguero B., Jiménez V., Filali-Mouhim A., Ghneim K., Haddad E.K., Quakkelaar E.D., Delaloye J., Harari A., Roger T., Dunhen T., Sékaly R.P., Melief C.J., Calandra T., Sallusto F., Lanzavecchia A., Wagner R., Pantaleo G. and Esteban M.
    Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.
PLoS One 2012, 7:e35485
16: Haddad E.K. and Pantaleo G.
    Systems biology in the development of HIV vaccines.
Curr. Opin. HIV AIDS 2012, 7:44-49.
17: Hafner A.M., Burschowsky D., Corthésy B., Textor M. and Merkle H.P.
    Surface assembly of poly(I:C) on PEGylated microspheres to shield from adverse interactions with fibroblasts.
J. Control Release 2012, 159:204-214.
18: Harari A., Rozot V., Cavassini M., Enders F.B., Vigano S., Tapia G., Castro E., Burnet S., Lange J., Moog C., Garin D., Costagliola D., Autran B., Pantaleo G. and Bart P.-A.
    NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
Eur. J. Immunol. 2012, 42:3038-3048.
19: Hunger R.E., Della Torre R., Serov A. and Hunziker T.
    Assessment of melanocytic skin lesions with a high-definition laser Doppler imaging system.
Skin. Res. Technol. 2012, 18:207-211.
20: Jilek S., Schluep M., Harari A., Canales M., Lysandropoulos A., Zekeridou A., Pantaleo G. and Du Pasquier R.A.
    HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in Multiple Sclerosis.
J. Immunol. 2012, 188:4671-4680.
21: Kaech C., Pache I., Bürgisser P., Elzi L., Darling K.E. and Cavassini M.
    Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
J. Infect. 2012, 65:157-164.
22: King C.G., Koehli S., Hausmann B., Schmaler M., Zehn D. and Palmer E.
    T cell affinity regulates asymmetric division, effector cell differentiation, and tissue pathology.
Immunity 2012, 37:709-720.
23: Langenskiöld E., Bonetti A., Fitting J.W., Heinzer R., Dudler J., Spertini F. and Lazor R.
    Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide.
Respiration 2012, 84:144-149.
24: Leventhal G.E., Kouyos R., Stadler T., von Wyl V., Yerly S., Böni J., Cellerai C., Klimkait T., Günthard H.F. and Bonhoeffer S.
    Inferring epidemic contact structure from phylogenetic trees.
PLoS Comput Biol. 2012, 8:e1002413.
25: Ludigs K., Parfenov V., Du Pasquier R.A. and Guarda G.
    Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
Cell. Mol. Life Sci., 2012, 69:3395-3418.
26: Marek D., Papin S., Ellefsen K., Niederhauser J., Isidor N., Ransijn A., Poupon L., Spertini F., Pantaleo G., Bergmann S., Beckmann J.S., Jacquemont S. and Tanackovic G.
    Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10.
J. Neuroinflammation 2012, 9:238.
27: McNerney R., Maeurer M., Abubakar I., Marais B., McHugh T.D., Ford N., Weyer K., Lawn S., Grobusch M.P., Memish Z., Squire S.B., Pantaleo G., Chakaya J., Casenghi M., Migliori G.B., Mwaba P., Zijenah L., Hoelscher M., Cox H., Swaminathan S., Kim P.S., Schito M., Harari A., Bates M., Schwank S., O'Grady J., Pletschette M., Ditui L., Atun R. and Zumla A.
    Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.
J. Infect. Dis. 2012, 205 Suppl 2:S147-158.
28: Miconnet I.
    Probing the T-cell receptor repertoire with deep sequencing.
Curr. Opin. HIV AIDS 2012, 7:64-70.
29: Orcurto A., Pascual M., Hoschler K., Aubert V., Meylan P. and Manuel O.
    Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients.
Transplantation 2012, 94:630-636.
30: Papadopoulos N.G., Agache I., Bavbek S., Bilo B.M., Braido F., Cardona V., Custovic A., Demonchy J., Demoly P., Eigenmann P., Gayraud J., Grattan C., Heffler E., Hellings P.W., Jutel M., Knol E., Lötvall J., Muraro A., Poulsen L.K., Roberts G., Schmid-Grendelmeier P., Skevaki C., Triggiani M., Vanree R., Werfel T., Flood B., Palkonen S., Savli R., Allegri P., Annesi-Maesano I., Annunziato F., Antolin-Amerigo D., Apfelbacher C., Blanca M., Bogacka E., Bonadonna P., Bonini M., Boyman O., Brockow K., Burney P., Buters J., Butiene I., Calderon M., Cardell L.O., Caubet J.C., Celenk S., Cichocka-Jarosz E., Cingi C., Couto M., Dejong N., Del Giacco S., Douladiris N., Fassio F., Fauquert J.L., Fernandez J., Rivas M.F., Ferrer M., Flohr C., Gardner J., Genuneit J., Gevaert P., Groblewska A., Hamelmann E., Hoffmann H.J., Hoffmann-Sommergruber K., Hovhannisyan L., Hox V., Jahnsen F.L., Kalayci O., Kalpaklioglu A.F., Kleine-Tebbe J., Konstantinou G., Kurowski M., Lau S., Lauener R., Lauerma A., Logan K., Magnan A., Makowska J., Makrinioti H., Mangina P., Manole F., Mari A., Mazon A., Mills C., Mingomataj E., Niggemann B., Nilsson G., Ollert M., O'Mahony L., O'Neil S., Pala G., Papi A., Passalacqua G., Perkin M., Pfaar O., Pitsios C., Quirce S., Raap U., Raulf-Heimsoth M., Rhyner C., Robson-Ansley P., Alves R.R., Roje Z., Rondon C., Rudzeviciene O., Ruëff F., Rukhadze M., Rumi G., Sackesen C., Santos A.F., Santucci A., Scharf C., Schmidt-Weber C., Schnyder B., Schwarze J., Senna G., Sergejeva S., Seys S., Siracusa A., Skypala I., Sokolowska M., Spertini F., Spiewak R., Sprikkelman A., Sturm G., Swoboda I., Terreehorst I., Toskala E., Traidl-Hoffmann C., Venter C., Vlieg-Boerstra B., Whitacker P., Worm M., Xepapadaki P. and Akdis C.A.
    Research needs in allergy: an EAACI position paper, in collaboration with EFA.
Clin. Transl. Allergy 2012, 2:21.
31: Pattacini L., Mize G.J., Graham J.B., Fluharty T.R., Graham T.M., Lingnau K., Wizel B., Perdiguero B., Esteban M., Pantaleo G., Shen M., Spies G.A., McElrath M.J. and Lund J.M.
    A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.
PLoS One 2012, 7:e42163.
32: Pellaton C., Nutten S., Thierry A.C., Boudousquié C., Barbier N., Blanchard C., Corthésy B., Mercenier A. and Spertini F.
    Intragastric and intranasal administration of Lactobacillus paracasei NCC2461 modulates allergic airway inflammation in mice.
Int. J. Inflam. 2012, 2012:686739.
33: Perdiguero B., Gómez C.E., Nájera J.L., Sorzano C.O., Delaloye J., González-Sanz R., Jiménez V., Roger T., Calandra T., Pantaleo G. and Esteban M.
    Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens.
PLoS One 2012, 7:e48524.
34: Perreau M, Welles C. H, Pellaton C, Gjoksi B, Potin L, Martin R, Harari A, Bett A, Casimiro D, Gall J, Barouch H. D, Kremer J. E, Pantaleo G.
    The Number of TLR9-Agonist Motifs in the Adenovirus Genome Correlates with Induction of DC Maturation by Adenovirus Immune Complexes.
J. Virol. Jun;86(11):6279-85
35: Perreau M., Welles H.C., Harari A., Calandra T., Roger T. and Pantaleo G.
    Modulation of human memory T-cell function by different antigen-presenting cells.
Eur. J. Immunol. 2012, 42:799-802.
36: Perreau M., Welles H.C., Pellaton C., Gjoksi B., Potin L., Martin R., Harari A., Bett A., Casimiro D., Gall J., Barouch D.H., Kremer E.J., and Pantaleo G.
    The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes.
J. Virol. 2012, 86:6279-6285.
37: Rol N., Favre L., Benyacoub J. and Corthésy B.
    The role of secretory immunoglobulin A in the natural sensing of commensal bacteria by mouse Peyer's patch dendritic cells.
J. Biol. Chem. 2012, 287:40074-40082.
38: Rossier V., Bart P.-A. and Spertini F.
    Sjögren's syndrome: a new approach to treatment.
Rev. Med. Suisse 2012, 8:843-847.
39: Scherrer A.U., Böni J., Yerly S., Klimkait T., Aubert V., Furrer H., Calmy A., Cavassini M., Elzi L., Vernazza P.L., Bernasconi E., Ledergerber B., Günthard H.F.; the Swiss HIV Cohort Study (SHCS).
    Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
PLoS One 2012, 7:e50307.
40: Scherrer A.U., Ledergerber B., von Wyl V., Böni J., Yerly S., Klimkait T., Cellerai C., Furrer H., Calmy A., Cavassini M., Elzi L., Vernazza P.L., Bernasconi E., Günthard H.F. and the Swiss HIV Cohort Study.
    Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
PLoS One 2012, 7:e37983.
41: Scherrer A.U., von Wyl V., Götte M., Klimkait T., Cellerai C., Yerly S., Böni J., Held L., Ledergerber B., Günthard H.F. and the Swiss HIV Cohort Study.
    Polymorphic mutations associated with the emergence of the multinucleoside/tide resistance mutations 69 insertion and Q151M.
J. Acquir. Immune Defic. Syndr. 2012, 59:105-112.
42: Schluep M. and Du Pasquier R.
    Multiple sclerosis: beyong first line therapies.
Rev. Med. Suisse 2012, 8:946-949.
43: Schmidt C., Smith C., Barin B., Bakhtyari A., Bart P.-A., Bekker L.-G., Chomba E., Clumeck N., Ho D., Hoosen A., Jaoko W., Kaleebu P., Karita E., Keefer M.C., van Lunzen J., McMichael A., Mehendale S., Peters B., Ramanathan V., Robinson A., Rockstroh J., Vardas E., Vets E., Weber J., Graham B.S., Than S., Excler J.L., Kochhar S., Ho M., Heald A. and Fast P.E.
    Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events.
Hum. Vaccin Immunother. 2012, 8:630-638.
44: Schwab N., Höhn K.G., Schneider-Hohendorf T., Metz I., Stenner M.P., Jilek S., Du Pasquier R.A., Gold R., Meuth S.G., Ransohoff R.M., Brück W. and Wiendl H.
    Immunological and clinical consequences of treating a patient with natalizumab.
Mult. Scler. 2012, 18:335-344.
45: Schwab N., Ulzheimer J.C., Fox R.J., Schneider-Hohendorf T., Kieseier B.C., Monoranu C.M., Staugaitis S.M., Welch W., Jilek S., Du Pasquier R.A., Brück W., Toyka K.V., Ransohoff R.M. and Wiendl H.
    Fatal PML associated with efalizumab therapy: Insights into integrin αLβ2 in JC virus control.
Neurology 2012, 78:458-467.
46: Spertini F. and Seebach J.D.
    Drug allergies.
Rev. Med. Suisse 2012, 8:827-828.
47: Stadler T., Kouyos R., von Wyl V., Yerly S., Böoni J., Bürgisser P., Klimkait T., Joos B., Rieder P., Xie D., Günthard H.F., Drummond A.J., Bonhoeffer S. and the Swiss HIV Cohort Study.
    Estimating the basic reproductive number from viral sequence data.
Mol. Biol. Evol. 2012, 29:347-357.
48: Stravodimou A., Cairoli A., Rausch T., Du Pasquier R. and Michel P.
    PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis.
Case Report Med. 2012, 2012:239719.
49: Vardas E., Stanescu I., Leinonen M., Ellefsen K., Pantaleo G., Valtavaara M., Ustav M. and Reijonen K.
    Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects.
Vaccine 2012, 30:4046-4054.
50: Viganò S. , Utzschneider D.T. , Perreau M. , Pantaleo G. , Zehn D. , Harari A.
    Functional avidity: a measure to predict the efficacy of effector T cells?
Clinical and Developmental Immunology p.153863.
51: Viganò S., Perreau M., Pantaleo G. and Harari A.
    Positive and negative regulation of cellular immune responses in physiologic conditions and diseases.
Clin. Dev. Immunol. 2012, 2012:485781.
52: Zehn D., King C., Bevan M.J. and Palmer E.
    TCR signaling requirements for activating T cells and for generating memory.
Cell. Mol. Life Sci. 2012, 69:1565-1575.

Publications : 2011 Debut de page

1: Bart P.-A.
    Allergy-immunology. Do we have to be afraid of biological agents ?
Rev. Med. Suisse 2011, 7:106-107.
2: Blüggel M., Spertini F., Lutter P., Wassenberg J., Audran R., Corthésy B., Müllner S., Blum S., Wattenberg A., Mercenier A., Affolter M. and Kussmann M.
    Toward protein biomarkers for allergy: CD4+ T cell proteomics in allergic and nonallergic subjects sampled in and out of pollen season.
J. Proteome. Res. 2011, 10:1558-1570.
3: Cellerai C., Harari A., Stauss H., Yerly S., Geretti A.-M., Carroll A., Yee T., Ainsworth J., Williams I., Sweeney J., Freedman A., Johnson M., Pantaleo G. and Kinloch-de Loes S.
    Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors.
PLoS One 2011, 6:e18164.
4: Comte D., Petitpierre S., Bart P.-A., Leimgruber A. and Spertini F.
    Hymenoptera venom allergy: new diagnostic tools and management.
Rev. Med. Suisse 2011, 7: 844-849.
5: Corey L., Nabel G.J., Dieffenbach C., Gilbert P., Haynes B.F., Johnston M., Kublin J., Lane H.C., Pantaleo G., Picker L.J. and Fauci A.S.
    HIV-1 vaccines and adaptive trial designs.
Sci. Transl. Med. 2011, 3:79ps13.
6: Fehr J., Glass T.R., Louvel S., Hamy F., Hirsch H.H., von Wyl V., Böni J., Yerly S., Bürgisser P., Cavassini M., Fux C.A., Hirschel B., Vernazza P., Martinetti G., Bernasconi E., Günthard H.F., Battegay M., Bucher H.C., Klimkait T. and the Swiss HIV Cohort Study.
    Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.
J. Transl. Med. 2011, 9:14.
7: Flynn B.J., Kastenmüller K., Wille-Reece U., Tomaras G.D., Alam M., Lindsay R.W., Salazar A.M., Perdiguero B., Gomez C.E., Wagner R., Esteban M., Park C.G., Trumpfheller C., Keler T., Pantaleo G., Steinman R.M. and Seder R.
    Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
Proc. Natl. Acad. Sci. USA 2011, 108:7131-7136.
8: Forbes S.J., Bumpus T., McCarthy E.A., Corthésy B. and Mantis NJ.
    Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA.
MBio. 2011, 2:e00042-11.
9: Gaillard J., Bart P.-A., Leimgruber A. and Spertini F.
    Allergen specific immunotherapy: review of new perspectives.
Rev. Med. Suisse 2011, 7:850-855.
10: García F., Bernaldo de Quirós J.C., Gómez C.E., Perdiguero B., Nájera J.L., Jiménez V., García-Arriaza J., Guardo A.C., Pérez I., Díaz-Brito V., Conde M.S., González N., Alvarez A., Alcamí J., Jiménez J.L., Pich J., Arnaiz J.A., Maleno M.J., León A., Muñoz-Fernández M.A., Liljeström P., Weber J., Pantaleo G., Gatell J.M., Plana M. and Esteban M.
    Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Vaccine 2011, 29:8309-8316.
11: Giannoni E., Guignard L., Knaup Reymond M., Perreau M., Roth-Kleiner M., Calandra T. and Roger T.
    Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns.
Infect. Immun. 2011, 79:2690-2698.
12: Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Förster I., Farlik M., Decker T., Du Pasquier R.A., Romero P. and Tschopp J.
    Type I interferon inhibits interleukin-1 production and inflammasome activation.
Immunity 2011, 34:213-223.
13: Hafner A.M., Corthésy B., Textor M. and Merkle HP.
    Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling.
Biomaterials 2011, 32:2651-2661.
14: Harari A., Rozot V., Bellutti Enders F., Perreau M., Mazza Stalder J., Nicod L.P., Cavassini M., Calandra T., Lazor Blanchet C., Jaton C., Faouzi M., Day C.L., Hanekom W.A., Bart P.-A. and Pantaleo G.
    Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease.
Nat. Med. 2011, 17:372-376.
15: Kaufmann A., Kenfak-Foguena A., André C., Canellini G., Bürgisser P., Moradpour D., Darling K.E. and Cavassini M.
    Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.
PLoS One 2011, 6:e21150.
16: Kenfak-Foguena A., Schöni-Affolter F., Bürgisser P., Witteck A., Darling K.E., Kovari H., Kaiser L., Evison J.M., Elzi L., Gurter-De La Fuente V., Jost J., Moradpour D., Abravanel F., Izpopet J., Cavassini M. and the Swiss HIV Cohort Study.
    Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.
Emerg. Infect. Dis. 2011, 17:1074-1078.
17: Kibler K.V., Gomez C.E., Perdiguero B., Wong S., Huynh T., Holechek S., Arndt W., Jimenez V., Gonzalez-Sanz R., Denzler K., Haddad E.K., Wagner R., Sékaly R.-P., Tartaglia J., Pantaleo G., Jacobs B.L. and Esteban M.
    Improved NYVAC-based vaccine vectors.
PLoS One 2011, 6:e25674.
18: Kuntzer T., Carota A., Novy J., Cavassini M. and Du Pasquier R.A.
    Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.
Neurology 2011, 76:757-758.
19: Leimgruber A.
    Allergy-immunology. New therapies for acute attacks in hereditary angioedema.
Rev. Med. Suisse 2011, 7:103-105.
20: Leuppi J.D., Wildhaber J.H., Spertini F. and Helbling A.
    Intermittent or persistent rhinitis in children and adolescents with Asthma: «the Swiss LARA paediatrics survey».
Praxis (Bern 1994) 2011, 100:1225-1234.
21: Lysandropoulos A.P., Jaquiéry E., Jilek S., Pantaleo G., Schluep M. and Du Pasquier R.A.
    Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.
J. Neuroimmunol. 2011, 233:240-244.
22: Mantis N.J., Rol N. and Corthésy B.
    Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.
Mucosal Immunol. 2011, 4:603-611.
23: Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.-A., Venetz J.-P., Calandra T. and Cavassini M.
    Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients.
Clin. Infect. Dis. 2011, 52:248.256.
24: Mathias A. and Corthésy B.
    N-Glycans on secretory component: Mediators of the interaction between secretory IgA and gram-positive commensals sustaining intestinal homeostasis.
Gut Microbes 2011, 2:287-293.
25: Mathias A. and Corthésy B.
    Recognition of gram-positive intestinal bacteria by hybridoma- and colostrum-derived secretory immunoglobulin A is mediated by carbohydrates.
J. Biol. Chem. 2011, 286:17239-17247.
26: Miconnet I., Marrau A., Farina A., Taffé P., Vigano S., Harari A. and Pantaleo G.
    Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure.
J. Immunol. 2011, 186:7039-7049.
27: Mooij P., Nieuwenhuis I., Beenhakker N., Quakkelaar E.D., Heeney J.L., Esteban M., Jacobs B., Pantaleo G., Bogers W.M., Melief C.
    Boosting of Replication Competent NYVAC Primed HIV-1-Specific T-Cell Responses by HIV Synthetic Long Peptides (SLP)
pp. A96-A97 in AIDS Vaccine 2011 Conference.
28: Olugbile S., Villard V., Bertholet S., Jafarshad A., Kulangara C., Roussilhon C., Frank G., Agak G.W., Felger I., Nebie I., Konate K., Kajava A.V., Schuck P., Druilhe P., Spertini F. and Corradin G.
    Malaria vaccine candidate: design of a multivalent subunit α-helical coiled coil poly-epitope.
Vaccine 2011, 29:7090-7099.
29: Paladini F., Cocco E., Potolicchio I., Fazekasova H., Lombardi G., Fiorillo M.T. and Sorrentino R.
    Divergent effect of cobalt and beryllium salts on the fate of peripheral blood monocytes and T lymphocytes.
Toxicol. Sci. 2011, 119:257-269.
30: Pellaton-Longaretti C., Boudousquié C., Barbier N., Barbey C., Argiroffo C.B., Donati Y., Sauty A. and Spertini F.
    CD4+CD25-mTGFbeta+ T cells induced by nasal application of ovalbumin transfer tolerance in a therapeutic model of asthma.
Int. Immunol. 2011, 23:17-27.
31: Perreau M, Welles C. H, Harari A, Calandra T, Roger T, Pantaleo G.
    Modulation of human memory T-cell function by different antigen-presenting cells.
Eur J Immunol. 2011 Dec 5. doi: 10.1002/eji.201142094
32: Perreau M., Welles H.C., Harari A., Hall O., Martin R., Maillard M., Dorta G., Bart P.-A., Kremer E.J., Tartaglia J., Wagner R., Esteban M., Levy Y. and Pantaleo G.
    DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.
J. Virol. 2011, 85:9854-9862.
33: Perrier C. and Corthésy B.
    Gut permeability and food allergies.
Clin. Exp. Allergy 2011, 41:20-28.
34: Quakkelaar E.D., Redeker A., Haddad E.K., Harari A., McCaughey S.M., Duhen T., Filali-Mouhim A., Goulet J.P., Loof N.M., Ossendorp F., Perdiguero B., Heinen P., Gomez C.E., Kibler K.V., Koelle D.M., Sékaly R.P., Sallusto F., Lanzavecchia A., Pantaleo G., Esteban M., Tartaglia J., Jacobs B.L. and Melief C.J.
    Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors.
PLoS One 2011, 6:e16819.
35: Riond P.
    L'implication du laboratoire dans la médecine des grands brûlés.
Labmed Suisse 2011, 38:167-171.
36: Roger T., Lugrin J., Le Roy D., Goy G., Mombelli M., Koessler T., Ding X.C., Chanson A.L., Reymond M.K., Miconnet I., Schrenzel J., François P. and Calandra T.
    Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection.
Blood 2011, 117:1205-1217.
37: Rozot V., Perreau M., Harari A. and Pantaleo G.
    Immunological signatures: a new tool to diagnose active tuberculosis disease ?
Med. Sci. (Paris) 2011, 27:808-811.
38: Schüpbach J., Bisset L.R., Regenass S., Bürgisser P., Gorgievski M., Steffen I., Andreutti C., Martinetti G., Shah C., Yerly S., Klimkait T., Gebhardt M., Schöni-Affolter F., Rickenbach M. and the Swiss HIV Cohort Study.
    High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.
BMC Infect. Dis. 2011, 11:254.
39: Scherrer A.U., von Wyl V., Böni J., Yerly S., Klimkait T., Bürgisser P., Garzoni C., Hirschel B., Cavassini M., Battegay M., Vernazza P.L., Bernasconi E., Ledergerber B., Günthard H.F. and the Swiss HIV Cohort Study (SHCS).
    Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors.
J. Acquir. Immune Defic. Syndr. 2011, 57:24-31.
40: Scherrer A.U., von Wyl V., Joos B., Klimkait T., Bürgisser P., Yerly S., Böni J., Ledergerber B., Günthard H.F. and the Swiss HIV Cohort Study.
    Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study.
J. Infect. Dis. 2011, 203:791-797.
41: Seebach J.D. and Spertini F.
    In process citation.
Rev. Med. Suisse 2011, 7:835-836.
42: Siegert S., Huang H.Y., Yang C.Y., Scarpellino L., Carrie L., Essex S., Nelson P.J., Heikenwalder M., Acha-Orbea H., Buckley C.D., Marsland B.J., Zehn D. and Luther S.A.
    Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide.
PLoS One 2011, 6:e27618.
43: Spertini F., Leimgruber A. and Bart P.-A.
    What to expect from novel generation of allergy test ?
Rev. Med. Suisse 2011, 7: 856-859.
44: Vallotton L., Hadaya K., Venetz J.-P., Buehler L.H., Ciuffreda D., Nseir G., Codarri L., Villard J., Pantaleo G. and Pascual M.
    Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.
Clin. J. Am. Soc. Nephrol. 2011, 6:2025-2033.
45: Wassenberg J., Nutten S., Audran R., Barbier N., Aubert V., Moulin J., Mercenier A. and Spertini F.
    Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis.
Clin. Exp. Allergy 2011, 41:565-573.
46: von Wyl V., Kouyos R.D., Yerly S., Böni J., Shah C., Bürgisser P., Klimkait T., Weber R., Hirschel B., Cavassini M., Staehelin C., Battegay M., Vernazza P.L., Bernasconi E., Ledergerber B., Bonhoeffer S., Günthard H.F. and the Swiss HIV Cohort Study.
    The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland.
J. Infect. Dis. 2011, 204:1095-1103.

Publications : 2010 Debut de page

1: Alizon S., von Wyl V., Stadler T., Kouyos R.D., Yerly S., Hirschel B., Böni J., Shah C., Klimkait T., Furrer H., Rauch A., Vernazza P.L., Bernasconi E., Battegay M., Bürgisser P., Telenti A., Günthard H.F., Bonhoeffer S. and the Swiss HIV Cohort Study.
    Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
PLoS Pathogens 2010, 6:1-9.
2: Aubert C., Vaudaux B. and Bart P.-A.
    Immunization guidelines regarding patients with a chronic disease.
Rev. Med. Suisse 2010, 6:798-803.
3: Baltcheva I., Codarri L., Pantaleo G. and Le Boudec J.Y.
    Lifelong dynamics of human CD4+CD25+ regulatory T cells: insights from in vivo data and mathematical modeling.
J. Theor. Biol. 2010, 266:307-322.
4: Boyman O., Cho J.H. and Sprent J.
    The role of interleukin-2 in memory CD8 cell differentiation.
Adv. Exp. Med. Biol. 2010, 684:28-41.
5: Boyman O.
    Bystander activation of CD4+ T cells.
Eur. J. Immunol. 2010, 40:936-939.
6: Castro E., Khonkarly M., Ciuffreda D., Bürgisser P., Cavassini M., Yerly S., Pantaleo G. and Bart P.-A.
    HIV-1 drug resistance transmission networks in Southwest Switzerland.
Aids Res. Hum. Retrov. 2010, 26:1233-1238.
7: Cellerai C., Perreau M., Rozot V., Enders F.B., Pantaleo G. and Harari A.
    Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression.
J. Virol. 2010, 84:3868-3878.
8: Chappuis S., Vogt P., Petitpierre S., Leimgruber A., Spertini F. and Bart P.-A.
    Cardiac involvement in connective tissue disease: the example of systemic lupus erythematosus.
Rev. Med. Suisse 2010, 6:804, 806-811.
9: Ciuffreda D., Codarri L., Buhler L., Vallotton L., Giostra E., Mentha G., Morel P., Pantaleo G. and Pascual M.
    Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4+CD25+CD45RO+IL-7ralpha(high) T cells.
Liver Transpl. 2010, 16:49-55.
10: Corthésy B.
    Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces.
Future Microbiol. 2010, 5:817-829.
11: Cvetkovic-Lopes V., Bayer L., Dorsaz S., Maret S., Pradervand S., Dauvilliers Y., Lecendreux M., Lammers G.J., Donjacour C.E., Du Pasquier R.A., Pfister C., Petit B., Hor H., Mühlethaler M. and Tafti M.
    Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
J. Clin. Invest. 2010, 120:713-719.
12: Decrausaz L, Revaz V, Bobst M, Corthésy B, Romero P, Nardelli-Haefliger D.
    Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice.
Int. J. Cancer 2010, 126:2469-2478.
13: Du Pasquier R.A.
    A promenade along the stream of demyelination.
Curr. Opin. Neurol. 2010, 23:203-204.
14: Duc M., Johansen F.E. and Corthésy B.
    Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors.
J. Biol. Chem. 2010, 285:953-960.
15: Duchez S., Amin R., Cogné N., Delpy L., Sirac C., Pascal V., Corthésy B. and Cogné M.
    Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation.
Proc. Natl. Acad. Sci. USA 2010, 107:3064-3069.
16: Dunand M., Botez S.A., Borruat F.X., Roux-Lombard P., Spertini F. and Kuntzer T.
    Unsatisfactory outcomes in myasthenia gravis: influence by care providers.
J. Neurol. 2010, 257:338-343.
17: Elzi L., Marzolini C., Furrer H., Ledergerber B., Cavassini M., Hirschel B., Vernazza P., Bernasconi E., Weber R., Battegay M.; Swiss HIV Cohort Study.
    Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Arch. Intern. Med. 2010, 170:57-65.
18: Fontana M., Moradpour D., Aubert V., Pantaleo G. and Pascual M.
    Prevalence of anti-HLA antibodies after liver transplantation.
Transpl. Int. 2010, 23:858-859.
19: Gambillara E., Spertini F. and Leimgruber A.
    Allergic and toxic cutaneous reactions to plants.
Rev. Med. Suisse 2010, 6:824-829.
20: Genton B., D'Acremont V., Lurati-Ruiz F., Verhage D., Audran R., Hermsen C., Wolters L., Reymond C., Spertini F. and Sauerwein R.
    Randomized double-blind controlled Phase I/IIa trial to assess the efficacy of malaria vaccine PfCS102 to protect against challenge with P. falciparum.
Vaccine 2010, 28:6573-6580.
21: Gerlach C., van Heijst J.W., Swart E., Sie D., Armstrong N., Kerkhoven R.M., Zehn D., Bevan M.J., Schepers K. and Schumacher T.N.
    One naive T cell, multiple fates in CD8+ T cell differentiation.
J. Exp. Med. 2010, 207:1235-1246.
22: Guglietta S., Pantaleo G. and Graziosi C.
    Length variation in HIV-1 gp120 as the product of DNA misalignment mechanism.
Retrovirology 2010, 7:21. Suppl.1
23: Guglietta S., Pantaleo G. and Graziosi C.
    Long sequence duplications, repeats and palindromes in HIV-1 gp120: length variation in V4 as the product of misalignment mechanism.
Virology 2010, 399:167-175.
24: Hadaya K., Avila Y., Valloton L., de Rham C., Bandelier C., Ferrari-Lacraz S., Pascual M., Pantaleo G., Martin P.Y., Buhler L. and Villard J.
    Natural killer cell receptor-Repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients.
Clin. Immunol. 2010, 137:250-260.
25: Harari A., Vigano S., Bellutti Enders F., Cellerai C., Castro E., Cavassini M., Bart P.-A. and Pantaleo G.
    Modulation of TCR avidity of primary HIV-1-specific CD8 T-cell responses by early and potent antiviral therapy responses.
Aids Res. Hum. Retrov. 2010, 26:A7-A8.
26: Jaquiéry E., Jilek S., Schluep M., Le Goff G., Garcia M., Pantaleo G. and Du Pasquier R.A.
    Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: A pilot study.
J. Neuroimmunol. 2010, 225:167-170.
27: Jaquiéry E., Jilek S., Schluep M., Meylan P., Lysandropoulos A., Pantaleo G. and Du Pasquier R.A.
    Intrathecal immune responses to Epstein-Barr virus in early multiple sclerosis.
Eur. J. Immunol. 2010, 40:878-887.
28: Jilek S., Jaquiéry E., Hirsch H.H., Lysandropoulos A., Canales M., Guignard L., Schluep M., Pantaleo G. and Pasquier R.A.
    Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
Lancet Neurol. 2010, 9:264-272.
29: Kibler K.V., Perdiguera B., Gomez C.E., Najera J.L., Gonzalez-Sanz R., Jimenez V., Quakkelaar E.D., Melief C.J., Haddad E., Sekaly R., Sallusto F., Lanzavecchia A., Harari A., Huynh T., Holechek S., Tartaglia J., Pantaleo G., Jacobs B.L. and Esteban M.
    Improvement of the HIV/AIDS vaccine candidate NYVAC-C by deletion of the viral type I IFN inhibitor and/or acquisition of replication competence.
Aids Res. Hum. Retrov. 2010, 26:A137.
30: Krieg C., Létourneau S., Pantaleo G. and Boyman O.
    Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells.
Proc. Natl. Acad. Sci. USA 2010, 107:11906-11911.
31: Létourneau S., van Leeuwen E.M., Krieg C., Martin C., Pantaleo G., Sprent J., Surh C.D. and Boyman O.
    IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25.
Proc. Natl. Acad. Sci. USA 2010, 107:2171-2176.
32: Levy Y., Ellefsen K., Stoehr W., Bart P.-A., Lelievre J., Launay O., Wolf H., Weber J., Chene G. and Pantaleo G.
    Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens requires 3 DNA injections. Results of the EV03/ANRS Vac20 Phase I/II Trial .
Aids Res. Hum. Retrov. 2010, 26:A10.
33: Lyko C., Bart P.-A., Pruvot E., Prior J. and Waeber G.
    Extrapulmonary sarcoidosis: an unrecognized affection ?
Rev. Med. Suisse 2010, 6:2056-2060.
34: Lysandropoulos A.P. and Du Pasquier R.A.
    Demyelination as a complication of new immunomodulatory treatments.
Curr. Opin. Neurol. 2010, 23:226-233.
35: Mathias A., Duc M., Favre L., Benyacoub J., Blum S. and Corthésy B.
    Potentiation of polarized intestinal Caco-2 cell responsiveness to probiotics complexed with secretory IgA.
J. Biol. Chem. 2010, 285:33906-33913.
36: Mooij P., Nieuwenhuis I., Beenhakker N., Hofman S., Esteban M., Jacobs B., Kibler K., Koopman G., Bogers W., Pantaleo G. and Heeney J.
    Improved immunogenicity against HIV-1 clade C antigens by using NYVAC-C with restored replication competence.
Aids Res. Hum. Retrov. 2010, 26:A4-A5.
37: Odman M. and Bart P.-A.
    Eosinophilic esophagitis.
Rev. Med. Suisse 2010, 6:1854-1856, 1858.
38: Olugbile S., Habel C., Servis C., Spertini F., Verdini A. and Corradin G.
    Malaria vaccines - The long synthetic peptide approach: Technical and conceptual advancements.
Curr. Opin. Mol. Ther. 2010, 12:64-76.
39: Oviedo-Orta E., Perreau M., Evans W.H. and Potolicchio I.
    Control of the proliferation of activated CD4+ T cells by connexins.
J. Leukoc. Biol. 2010, 88:79-86.
40: Pantaleo G., Esteban M., Jacobs B. and Tartaglia J.
    Poxvirus vector-based HIV vaccines.
Curr. Opin. HIV AIDS 2010, 5:391-396.
41: Perrier C., Thierry A.C., Mercenier A. and Corthésy B.
    Allergen-specific antibody and cytokine responses, mast cell reactivity and intestinal permeability upon oral challenge of sensitized and tolerized mice.
Clin. Exp. Allergy 2010, 40:153-162.
42: Rey V., Du Pasquier R., Muehl A., Péter O. and Michel P.
    Multiple ischemic strokes due to Borrelia garinii meningovasculitis.
Rev. Neurol. (Paris) 2010, 166:931-934.
43: Seebach J., Bart P.-A. and Spertini F.
    Prevention of transmissible diseases.
Rev. Med. Suisse 2010, 6:795-796.
44: Sellner J., Boggild M., Clanet M., Hintzen R.Q., Illes Z., Montalban X., Du Pasquier R.A., Polman C.H., Sorensen P.S. and Hemmer B.
    EFNS guidelines on diagnosis and management of neuromyelitis optica.
Eur. J. Neurol. 2010, 17:1019-1032.
45: Simioni S., Cavassini M., Anonni J.-M., Rimbault-Abraham A., Bourquin I., Schiffer V., Calmy A., Chave J.-P., Giacobini E., Hirschel B. and Du Pasquier R.A.
    Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.
AIDS 2010, 24:1243-1250.
46: Sizmann D., Glaubitz J., Simon C.O., Goedel S., Buergisser P., Drogan D., Hesse M., Kröh M., Simmler P., Dewald M., Gilsdorf M., Fuerst M., Ineichen R., Kirn A., Pasche P., Wang Z., Weisshaar S., Young K., Haberhausen G. and Babiel R.
    Improved HIV-1 RNA quantitation by COBAS((R)) AmpliPrep/COBAS((R)) TaqMan((R)) HIV-1 Test, v2.0 using a novel dual-target approach.
J. Clin. Virol. 2010, 49:41-46.
47: Spertini F., Berney M., Foradini F. and Roulet CA.
    Major mite allergen Der f 1 concentration is reduced in buildings with improved energy performance.
Allergy 2010, 65:623-629.
48: Wilks A.B., Christian E.C., Seaman M.S., Sircar P., Carville A., Gomez C.E., Esteban M., Pantaleo G., Barouch D.H., Letvin N.L., and Permar S.R.
    Robust vaccine-elicited cellular immune responses in breast milk following systemic Simian Immunodeficiency Virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.
J. Immunol. 2010, 185:7097-7106.
49: Zehn D., Turner M.J., Lefrançois L. and Bevan M.J.
    Lack of original antigenic sin in recall CD8+ T cell responses.
J. Immunol. 2010, 184:6320-6326.
50: von Wyl V., Ehteshami M., Demeter L.M., Bürgisser P., Nijhuis M., Symons J., Yerly S., Böni J., Klimkait T., Schuurman R., Ledergerber B., Götte M., Günthard H.F. and Swiss HIV Cohort Study.
    HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy.
Clin. Infect. Dis. 2010, 51:620-628.